Antitumor effect of FP3 in a breast cancer xenograft model

FP3 is a novel vascular endothelial growth factor (VEGF) blocker proposed to have antiangiogenic properties. Previous studies revealed that FP3 is a new promising agent for treating human choroidal neovascularization (CNV)-associated age-associated macular degeneration (AMD) and has an inhibitory ef...

Descripción completa

Detalles Bibliográficos
Autores principales: LAN, HUANRONG, ZHENG, LINGZHI, JIN, KETAO, TENG, LISONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524272/
https://www.ncbi.nlm.nih.gov/pubmed/23251246
http://dx.doi.org/10.3892/etm.2012.773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524272/
https://www.ncbi.nlm.nih.gov/pubmed/23251246
http://dx.doi.org/10.3892/etm.2012.773

Ejemplares similares